BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 19782690)

  • 1. Activation of the ghrelin receptor is described by a privileged collective motion: a model for constitutive and agonist-induced activation of a sub-class A G-protein coupled receptor (GPCR).
    Floquet N; M'Kadmi C; Perahia D; Gagne D; Bergé G; Marie J; Banères JL; Galleyrand JC; Fehrentz JA; Martinez J
    J Mol Biol; 2010 Jan; 395(4):769-84. PubMed ID: 19782690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agonist-induced conformational changes in bovine rhodopsin: insight into activation of G-protein-coupled receptors.
    Bhattacharya S; Hall SE; Vaidehi N
    J Mol Biol; 2008 Oct; 382(2):539-55. PubMed ID: 18638482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of tryptophan W276 and of two surrounding amino acid residues in the high constitutive activity of the ghrelin receptor GHS-R1a.
    Gozé C; Bergé G; M'Kadmi C; Floquet N; Gagne D; Galleyrand JC; Fehrentz JA; Martinez J
    Eur J Pharmacol; 2010 Sep; 643(2-3):153-61. PubMed ID: 20599926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complex of an active mu-opioid receptor with a cyclic peptide agonist modeled from experimental constraints.
    Fowler CB; Pogozheva ID; Lomize AL; LeVine H; Mosberg HI
    Biochemistry; 2004 Dec; 43(50):15796-810. PubMed ID: 15595835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular dynamics of a biophysical model for beta2-adrenergic and G protein-coupled receptor activation.
    Rubenstein LA; Zauhar RJ; Lanzara RG
    J Mol Graph Model; 2006 Dec; 25(4):396-409. PubMed ID: 16574446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ghrelin receptor inverse agonists: identification of an active peptide core and its interaction epitopes on the receptor.
    Holst B; Lang M; Brandt E; Bach A; Howard A; Frimurer TM; Beck-Sickinger A; Schwartz TW
    Mol Pharmacol; 2006 Sep; 70(3):936-46. PubMed ID: 16798937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of human ghrelin receptor (hGHS-R1a) model using a fragmental prediction approach and validation through docking analysis.
    Pedretti A; Villa M; Pallavicini M; Valoti E; Vistoli G
    J Med Chem; 2006 Jun; 49(11):3077-85. PubMed ID: 16722627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling GPCR active state conformations: the β(2)-adrenergic receptor.
    Simpson LM; Wall ID; Blaney FE; Reynolds CA
    Proteins; 2011 May; 79(5):1441-57. PubMed ID: 21337626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis for ligand binding and specificity in adrenergic receptors: implications for GPCR-targeted drug discovery.
    Huber T; Menon S; Sakmar TP
    Biochemistry; 2008 Oct; 47(42):11013-23. PubMed ID: 18821775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simulations of a G protein-coupled receptor homology model predict dynamic features and a ligand binding site.
    Wolf S; Böckmann M; Höweler U; Schlitter J; Gerwert K
    FEBS Lett; 2008 Oct; 582(23-24):3335-42. PubMed ID: 18775703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toward the active conformations of rhodopsin and the beta2-adrenergic receptor.
    Gouldson PR; Kidley NJ; Bywater RP; Psaroudakis G; Brooks HD; Diaz C; Shire D; Reynolds CA
    Proteins; 2004 Jul; 56(1):67-84. PubMed ID: 15162487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein-based virtual screening of chemical databases. II. Are homology models of G-Protein Coupled Receptors suitable targets?
    Bissantz C; Bernard P; Hibert M; Rognan D
    Proteins; 2003 Jan; 50(1):5-25. PubMed ID: 12471595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular modeling of A1 and A2A adenosine receptors: comparison of rhodopsin- and beta2-adrenergic-based homology models through the docking studies.
    Yuzlenko O; Kieć-Kononowicz K
    J Comput Chem; 2009 Jan; 30(1):14-32. PubMed ID: 18496794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of the constitutive activity of the ghrelin receptor by use of pharmacological tools and mutagenesis.
    Mokrosiński J; Holst B
    Methods Enzymol; 2010; 484():53-73. PubMed ID: 21036226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recognition of privileged structures by G-protein coupled receptors.
    Bondensgaard K; Ankersen M; Thøgersen H; Hansen BS; Wulff BS; Bywater RP
    J Med Chem; 2004 Feb; 47(4):888-99. PubMed ID: 14761190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanisms of ligand binding, signaling, and regulation within the superfamily of G-protein-coupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function.
    Kristiansen K
    Pharmacol Ther; 2004 Jul; 103(1):21-80. PubMed ID: 15251227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ghrelin receptor (GHS-R)-like receptor and its genomic organisation in rainbow trout, Oncorhynchus mykiss.
    Kaiya H; Mori T; Miyazato M; Kangawa K
    Comp Biochem Physiol A Mol Integr Physiol; 2009 Aug; 153(4):438-50. PubMed ID: 19361568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photolabelling the urotensin II receptor reveals distinct agonist- and partial-agonist-binding sites.
    Holleran BJ; Beaulieu ME; Proulx CD; Lavigne P; Escher E; Leduc R
    Biochem J; 2007 Feb; 402(1):51-61. PubMed ID: 17064254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide interactions with G-protein coupled receptors.
    Marshall GR
    Biopolymers; 2001; 60(3):246-77. PubMed ID: 11774230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Light-driven activation of beta 2-adrenergic receptor signaling by a chimeric rhodopsin containing the beta 2-adrenergic receptor cytoplasmic loops.
    Kim JM; Hwa J; Garriga P; Reeves PJ; RajBhandary UL; Khorana HG
    Biochemistry; 2005 Feb; 44(7):2284-92. PubMed ID: 15709741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.